Enhanced cytotoxicity of IL-24 gene-modified dendritic cells co-cultured with cytokine-induced killer cells to hepatocellular carcinoma cells

International Journal of Hematology

Volumn 92, Issue 2, 2010, Pages 276-282

  Yu, Xin ^a   Xia, Wei ^a   Zhang, Tao ^b,c   Wang, Hongwei ^b,c   Xie, Yufeng ^d   Yang, Jicheng ^d   Miao, Jingcheng ^d  

^a Wuxi Red Cross Blood Center   (China)

^b The Research Institute for Children at Children's Hospital New Orleans   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SOOCHOW UNIVERSITY   (China)

Author keywords

CIK cell; Cytotoxicity; Dendritic cell; Hepatocellular carcinoma; Interleukin 24

Indexed keywords

ADENOVIRUS VECTOR; B7 ANTIGEN; CD40 ANTIGEN; CD83 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; HLA DR ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 24; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CYTOKINE INDUCED KILLER CELL; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; FLOW CYTOMETRY; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIVER CELL CARCINOMA; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; TUMOR CELL;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; COCULTURE TECHNIQUES; CYTOKINE-INDUCED KILLER CELLS; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; HUMANS; INTERLEUKINS; TRANSFECTION;

EID: 77956901729     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0654-1     Document Type: Article

References (26)

1. B Bodey B Bodey Jr SE Siegel HE Kaiser 2000 Failure of cancer vaccines: the significant limitations of this approach to immunotherapy Anticancer Res 20 2665 2676 1:CAS:528:DC%2BD3cXlvFGjtbs%3D 10953341
2. FD Finkelman A Lees R Birnbaum WC Gause SC Morris 1996 Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion J Immunol 157 1406 1414 1:CAS:528:DyaK28XkvFWiu7Y%3D 8759720
3. FP Huang GG MacPherson 2001 Continuing education of the immune system-dendritic cells, immune regulation and tolerance Curr Mol Med 1 457 468 1:CAS:528:DC%2BD3MXmsVOgt7k%3D 10.2174/1566524013363573 11899090
4. FH Igney PH Krammer 2005 Tumor counterattack: fact or fiction? Cancer Immunol Immunother 54 1127 1136 10.1007/s00262-005-0680-7 15889255 (Pubitemid 41396816)
5. D Pardoll 2003 Does the immune system see tumors as foreign or self? Annu Rev Immunol 21 807 839 1:CAS:528:DC%2BD3sXjtF2is7c%3D 10.1146/annurev.immunol. 21.120601.141135 12615893 (Pubitemid 37174548)
6. TL Whiteside 2006 Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention Semin Cancer Biol 16 3 15 1:CAS:528:DC%2BD28XotVCmtA%3D%3D 10.1016/j.semcancer.2005.07.008 16153857 (Pubitemid 43139705)
7. CD Platsoucas JE Fincke J Pappas, et al. 2003 Immune responses to human tumors: development of tumor vaccines Anticancer Res 23 1969 1996 1:CAS:528:DC%2BD3sXmsFyrs7g%3D 12894571
8. L Rivoltini P Canese V Huber, et al. 2005 Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control? Expert Opin Biol Ther 5 463 476 1:CAS:528:DC%2BD2MXjt1yntb4%3D 10.1517/14712598.5.4.463 15934826 (Pubitemid 40593331)
9. DC Reid 2001 Dendritic cells and immunotherapy for malignant disease Br J Haematol 112 874 887 1:STN:280:DC%2BD3M3htVSjsQ%3D%3D 10.1046/j.1365-2141.2001. 02626.x 11298582 (Pubitemid 32322912)
10. IV Lebedeva ZZ Su Y Chang S Kitada JC Reed PB Fisher 2002 The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells Oncogene 21 708 718 1:CAS:528:DC%2BD38Xht1SrtbY%3D 10.1038/sj.onc.1205116 11850799
11. T Saeki A Mhashilkar S Chada C Branch JA Roth R Ramesh 2000 Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro Gene Ther 7 2051 2057 1:CAS:528:DC%2BD3cXoslWluro%3D 10.1038/sj.gt.3301330 11175318 (Pubitemid 32036772)
12. T Saeki A Mhashilkar X Swanson, et al. 2002 Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo Oncogene 21 4558 4566 1:CAS:528:DC%2BD38Xksl2mt7c%3D 10.1038/sj.onc.1205553 12085234 (Pubitemid 34785732)
13. Z Su IV Lebedeva RV Gopalkrishnan, et al. 2001 A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells Proc Natl Acad Sci USA 98 10332 10337 1:CAS:528:DC%2BD3MXmvFWiu74%3D 10.1073/pnas.171315198 11526239 (Pubitemid 32803020)
14. ZZ Su IV Lebedeva D Sarkar, et al. 2003 Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner Oncogene 22 1164 1180 1:CAS:528:DC%2BD3sXhsVyqsb8%3D 10.1038/sj.onc. 1206062 12606943 (Pubitemid 36363380)
15. EG Caudell JB Mumm N Poindexter, et al. 2002 The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24 J Immunol 168 6041 6046 1:CAS:528:DC%2BD38XksFWmtr4%3D 12055212
16. Sarkar D, Su ZZ, Lebedeva IV et al (2002) mda-7 (IL-24): signaling and functional roles. Biotechniques Suppl:30-39
17. JM Llovet M Beaugrand 2003 Hepatocellular carcinoma: present status and future prospects J Hepatol 38 Suppl 1 S136 S149 10.1016/S0168-8278(02)00432-4 12591191 (Pubitemid 39658641)
18. AX Zhu 2003 Hepatocellular carcinoma: are we making progress? Cancer Invest 21 418 428 10.1081/CNV-120018233 12901288 (Pubitemid 37055674)
19. AM Mhashilkar RD Schrock M Hindi, et al. 2001 Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy Mol Med 7 271 282 1:CAS:528:DC%2BD3MXktFyltrY%3D 11471572
20. PH Lu RS Negrin 1994 A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency J Immunol 153 1687 1696 1:CAS:528:DyaK2cXlslOmu7k%3D 7519209
21. H Jonuleit A Giesecke-Tuettenberg T Tuting, et al. 2001 A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection Int J Cancer 93 243 251 1:CAS:528:DC%2BD3MXltV2mtro%3D 10.1002/ijc.1323 11410873 (Pubitemid 32574281)
22. LD Cranmer KT Trevor EM Hersh 2004 Clinical applications of dendritic cell vaccination in the treatment of cancer Cancer Immunol Immunother 53 275 306 10.1007/s00262-003-0432-5 14648069 (Pubitemid 38392306)
23. D Gabrilovich 2004 Mechanisms and functional significance of tumour-induced dendritic-cell defects Nat Rev Immunol 4 941 952 1:CAS:528:DC%2BD2cXhtVarsb7P 10.1038/nri1498 15573129 (Pubitemid 39620069)
24. DM Pardoll 2002 Spinning molecular immunology into successful immunotherapy Nat Rev Immunol 2 227 238 1:CAS:528:DC%2BD38XjtFKhtrk%3D 10.1038/nri774 12001994
25. MJ Smyth DI Godfrey JA Trapani 2001 A fresh look at tumor immunosurveillance and immunotherapy Nat Immunol 2 293 299 1:CAS:528: DC%2BD3MXis1aktLs%3D 10.1038/86297 11276199 (Pubitemid 33706339)
26. EY Huang MT Madireddi RV Gopalkrishnan, et al. 2001 Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties Oncogene 20 7051 7063 1:CAS:528: DC%2BD3MXotlCgurs%3D 10.1038/sj.onc.1204897 11704829 (Pubitemid 33052197)